MAINOLFI NELLO (President and CEO) sold 7.0% of their position (50K shares) of KYMERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.95M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2026ACC: 0001193125-26-297817
DirectorOfficer· President and CEO
Since Aug 2020
-50K
Net shares
Net seller
$5.95M
Total sold
1
Open market trades
0B · 1S
4
Total transactions
50K acquired · 100K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$2.08
Trade value
$104K
% of position
7.5%
7/7/2026
666.57K→716.57K
Common Stock
Direct
Shares
−50K
Price / share
$119.00
Trade value
$5.95M
% of position
7.0%
7/7/2026
716.57K→666.57K
Total
Net shares
+0.00
Net value
-$5.85M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2026 | M · Option Exercise | +50K | $2.08 | $104K | 7.5% | 666.57K | 716.57K |
| Common Stock Direct | 7/7/2026 | S · Sale | −50K | $119.00 | $5.95M | 7.0% | 716.57K | 666.57K |
| Total | +0.00 | -$5.85M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
45.56K shares
Shares
−45.56K
Strike price
2.08
Held after
90K
Exercisable
—
7/7/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.44K shares
Shares
−4.44K
Strike price
2.08
Held after
14.28K
Exercisable
—
7/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock45.56K shares | 7/7/2026 | M · Option Exercise | −45.56K | 2.08 | — | 90K |
| Stock Option (Right to Buy) Direct | Common Stock4.44K shares | 7/7/2026 | M · Option Exercise | −4.44K | 2.08 | — | 14.28K |